Azitra, Inc. — fact timeline

Azitra, Inc.: Increased authorized common shares from 200,000,000 to 750,000,000 (effective 2026-06-15).

“On June 15, 2026, Azitra, Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware to increase the authorized shares of the Company’s common stock, par value $0.0001 per share, from 200,000,000 to 750,000,000 shares and to make a corresponding change to the number of authorized shares of capital stock (the “Authorized Share Increase”).”

Azitra, Inc. shareholders approved Adoption of amendment to Certificate of Incorporation to increase authorized common stock from 200,000,000 shares to 750,000,000 shares. at the 2026-06-15 meeting.

“Proposal No. 2. Stockholders approved the adoption of an amendment to the Company’s Certificate of Incorporation to increase the authorized number of shares of the Company’s common stock from 200,000,000 shares to 750,000,000 shares, with shares voted as follows: Votes Non-Votes 713,487 476,452 26,523 4,861,794”

Azitra, Inc. shareholders approved Election of four director nominees: Francisco D. Salva, Travis Whitfill, Barbara Ryan, and John Schroer. at the 2026-06-15 meeting.

“Proposal No. 1. Stockholders approved the election of the four director nominees named in the Proxy Statement to serve as members of the Board of Directors (the “Board”) of the Company until the next annual meeting of stockholders and until their successors are duly elected and qualified. The director nominees named in the Proxy Statement for election to the Company’s Board were the following individuals: Francisco D. Salva, Travis Whitfill, Barbara Ryan and John Schroer, with shares voted as follows: Name For Withheld Broker Non-Votes Francisco D. Salva 639,815 576,647 4,861,794 Travis Whitfill 642,109 574,353 4,861,794 Barbara Ryan 1,087,320 129,142 4,861,794 John Schroer 643,985 572,477 4,861,794”

Azitra, Inc. reported the quarter ended March 31, 2026 results: net income $3.9 million.

“Net Loss was $3.9 million for the quarter ended March 31, 2026, compared to $3.1 million for the comparable period in 2025.”

Azitra, Inc. issued Series C Warrants to purchase up to 85,233,126 shares of Common Stock of warrant to the Purchasers for exercise price of $0.123 per share.

“of the Company, and a holder of more than 5% of the Company’s outstanding Common Stock as of the date of the Purchase Agreement. The Warrants will each have an exercise price of $0.123 per share (the “Exercise Price”). The PIPE Financing closed on March 20, 2026 (the “Closing Date”). The PIPE Financing could result in gross proceeds of up to approximately $31.4”

Azitra, Inc. issued Series B Warrants to purchase up to 85,233,126 shares of Common Stock of warrant to the Purchasers for exercise price of $0.123 per share.

“of the Company, and a holder of more than 5% of the Company’s outstanding Common Stock as of the date of the Purchase Agreement. The Warrants will each have an exercise price of $0.123 per share (the “Exercise Price”). The PIPE Financing closed on March 20, 2026 (the “Closing Date”). The PIPE Financing could result in gross proceeds of up to approximately $31.4”

Azitra, Inc. issued 10,485 shares of preferred stock to the Purchasers for purchase price of $1,000.00 per Security.

“of Common Stock (collectively, each share of Series A Preferred Stock and Accompanying Warrants, a “Security”). The Securities are being sold at a purchase price of $1,000.00 per Security to the Purchasers, which includes the Company’s Chief Executive Officer, a consultant of the Company, and a holder of more than 5% of the Company’s outstanding Common”

Azitra, Inc.: Filed Certificate of Designations for Series A Preferred Stock (effective 2026-03-19).

“On March 19, 2026 (the “Filing Date”), the Company filed the Certificate of Designations with the Secretary of State of the State of Delaware designating 12,000 shares of its authorized and unissued preferred stock as Series A Preferred Stock.”

Azitra, Inc. entered into Securities Purchase Agreement with the purchasers named therein valued at gross proceeds of up to approximately $31.4 million (effective 2026-03-18).

“On March 18, 2026, Azitra, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell an aggregate of (i) 10,485 shares of its Series A convertible non-redeemable preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”), (ii) Series B warrants (the “Series B Warrants”) to purchase up to 85,233,126 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (or, in certain circumstances, pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”)), (iii) Series C warrants to purchase up to 85,233,126 shares of Common Stock (or, in certain circumstances, Pre-Funded Warrants) (the “Series C Warrants” and, together with the Series B Warrants, the “Warrants”) to the Purchasers in a private placement (the “PIPE Financing”).”

Azitra, Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(ii)).

“October 1, 2025, the Company received a letter from the NYSE American stating that the Company is not in compliance with the minimum stockholders’ equity requirement of Section 1003(a)(ii) of the Company Guide requiring stockholders’ equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years. The Company submitted the Plan to the NYSE American on October 31, 2025 addressing how the Company intends to regain compliance with these requirements by April 1, 2027. On December 16, 2025, the Company rece”

Azitra, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(iii)).

“March 13, 2026, Azitra, Inc. (the “Company”) received notification (the “Letter”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the minimum stockholders’ equity requirement of Section 1003(a)(iii) of the NYSE American Company Guide (the “Company Guide”) requiring stockholders’ equity of $6.0 million or more if the Company has reported losses from continuing operations and/or net losses in its five most recent fiscal years. As of December 31, 2025, the Company had stockholders’ equity of $3.8 million and has had losses in its five most recen”

Azitra, Inc. received a nyse_american extension granted notice regarding stockholders equity (rules 1003(a)(ii)).

“December 16, 2025, Azitra, Inc. (the “Company”) received notice (the “Letter”) from the NYSE American LLC (“NYSE American”) that it had accepted the Company’s plan (the “Plan”) to regain compliance with the NYSE American’s continued listing standards regarding the minimum stockholders’ equity requirement of Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) and granted a plan period through April 1, 2027 (“Plan Period Deadline”). As previously reported, on October 1, 2025, the Company received a letter from the NYSE American stating that the Company is not in complian”

Azitra, Inc. entered into Placement Agency Agreement with Maxim Group LLC (effective 2025-11-24).

“On November 24, 2025, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC, as sole placement agent (the “Placement Agent”)”

Azitra, Inc. entered into Securities Purchase Agreement with a single institutional investor valued at approximately $1.5 million (effective 2025-11-24).

“On November 24, 2025, Azitra, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with a single institutional investor (the “Purchaser”)”

Azitra, Inc. issued 187,500 shares of Common Stock of warrant to Maxim Group LLC, as sole placement agent for exercise price equal to 125% of the Offering Price.

“(the “Placement Agent Warrant Shares”), equal to 4.0% of the total number of shares of Common Stock and Pre-Funded Warrants sold in the Offering, at an exercise price equal to 125% of the Offering Price; and (iii) reimburse the Placement Agent for certain out of pocket expenses, including the reasonable fees of legal counsel, in an amount not to exceed”

Azitra, Inc. issued up to an aggregate of 4,687,500 shares of Common Stock of warrant to a single institutional investor for $0.32 per Common Warrant.

“up to an aggregate of 4,687,500 shares of Common Stock (the “Common Warrant Shares” together with the Pre-Funded Warrant Shares, the “Warrant Shares”) at an exercise price of $0.32 per Common Warrant. The offering price was $0.32 per share of Common Stock or Pre-Funded Warrant and accompanying Common Warrant (the “Offering Price”). The Pre-Funded Warrants”

Azitra, Inc. issued up to an aggregate of 4,151,741 shares of Common Stock of warrant to a single institutional investor for $0.0001 per Pre-Funded Warrant.

“private placement offering priced at a premium to market in accordance with NYSE rules (the “Offering”) an aggregate of 535,759 shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”), (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 4,151,741 shares of Common Stock (the “Pre-Funded”

Azitra, Inc. issued 535,759 shares of common stock of common stock to a single institutional investor for $0.32 per share.

“up to an aggregate of 4,687,500 shares of Common Stock (the “Common Warrant Shares” together with the Pre-Funded Warrant Shares, the “Warrant Shares”) at an exercise price of $0.32 per Common Warrant. The offering price was $0.32 per share of Common Stock or Pre-Funded Warrant and accompanying Common Warrant (the “Offering Price”). The Pre-Funded Warrants”

Azitra, Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(ii), 1009).

“October 1, 2025, Azitra, Inc. (the “Company”) received notification (the “Letter”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the minimum stockholders’ equity requirement of Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring stockholders’ equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years. As of June 30, 2025, the Company had stockholders’ equity of $2.2 million and has had losses in three of its f”

Azitra, Inc.: Filed a certificate of amendment to effect a 1-for-6.66 reverse stock split of common stock (effective 2025-08-21).

“On August 20, 2025, Azitra, Inc. (the “Company”) filed a certificate of amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effectuate a 1-for-6.66 reverse stock split (the “Reverse Stock Split”) of the outstanding shares of the Company’s common stock (“Common Stock”).”

Azitra, Inc.: Increased authorized shares of common stock from 100,000,000 to 200,000,000 (effective 2025-07-03).

“the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Certificate of Incorporation to implement the Authorized Share Increase”

Azitra, Inc. reported the quarter ended March 31, 2024 results: revenue $0, net income $2.9 million.

“Financial Results for the Year Ended December 31, 2023 ● Service Revenue – Related Party : The Company generated $0 service revenue during the quarter ended March 31, 2024, compared to $113,300 for the comparable period in 2023. ● Research and Development (R&D) expenses : R&D expenses for the quarter ended March 31, 2024, were $1.5 million compared to $0.8 million for the comparable period in 2023. ● General and Administrative (G&A) expenses : G&A expenses for the quarter ended March 31, 2024, were $1.5 million compared to $0.8 million for the comparable period in 2023. ● Net Loss was $2.9 million for the quarter ended March 31, 2024, compared to $2.5 million for the comparable period in 2023. ● Cash and cash equivalents : As of March 31, 2024, the Company had cash and cash equivalents of $3.0 million.”

Azitra, Inc. reported the full year ended December 31, 2023 results: revenue $0.7 million, net income $11.3 million.

“■ Execution of a licensing agreement with upfront payment Financial Results for the Year Ended December 31, 2023 ● Service Revenue – Related Party : The Company generated $0.7 million of service revenue during the year ended December 31, 2023, compared to $0.3 million for the comparable period in 2022. ● Research and Development (R&D) expenses : R&D”

Azitra, Inc. entered into Underwriting Agreement with ThinkEquity LLC valued at $5 million (effective 2024-02-13).

“On February 13, 2024, Azitra, Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with ThinkEquity LLC (the “Underwriter”), relating to an underwritten offering (the “Offering”) of 16,667,000 shares (“Shares”) of common stock of the Company (“Common Stock”).”

Azitra, Inc. reported the fiscal quarter ended September 30, 2023 results: net income $1.9 million.

“On November 14, 2023, Azitra, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 30, 2023.”

Azitra, Inc. reported second quarter ended June 30, 2023 results: revenue $172,000, net income $4.4 million.

“had cash and cash equivalents of $6.3 million, which includes the proceeds from an initial public offering in June 2023. ● Service Revenue – Related Party: The Company generated $172,000 of service revenue during the three months ended June 30, 2023 compared to service revenue of $85,000 for the comparable period in 2022. The increase of $87,000 in service revenue”

Azitra, Inc.: Amended and restated bylaws effective upon consummation of the IPO.

“The Amended and Restated Bylaws became effective immediately upon the consummation of the Offering.”

Azitra, Inc.: Amended and restated certificate of incorporation filed and effective June 21, 2023, in connection with closing of the IPO (effective 2023-06-21).

“The Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on June 21, 2023 and became effective on that date.”

Azitra, Inc. entered into Underwriting Agreement with ThinkEquity LLC valued at aggregate net proceeds of approximately $6.5 million (effective 2023-06-15).

“On June 15, 2023, Azitra, Inc., a Delaware corporation (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with ThinkEquity LLC, as representative (the "Representative") of the several underwriters identified therein, relating to the Company’s initial public offering (the "Offering") of 1,500,000 shares of the Company’s common stock, par value $0.0001 (the "Shares").”